Physician profile
Cody A Nebeker
NPI 1356755110
$15,009.10
in general payments reported to CMS, 2019-2025
17 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,576 · 2020: $239 · 2021: $1,732 · 2022: $257 · 2023: $9,908 · 2024: $50.88 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $1,147 · Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $1,147.10 |
| Food and Beverage | $557.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,210.35 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $2,560.84 | 2019-2021 | |
| Ethicon US, LLC | $679.63 | 2019-2023 | Dermabond Prineo, Stratafix |
| Kci USA, INC. | $650.00 | 2019 | |
| Tela Bio, INC. | $493.58 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Teleflex LLC | $134.85 | 2025 | Titan Sgs Bailout Chuck, Deknatel |
| Solventum Corporation | $63.26 | 2024-2025 | Prevena, V.A.C. Veraflo |
| Smith+Nephew, INC. | $41.89 | 2022 | |
| Allergan, INC. | $29.55 | 2021 | |
| Medtronic, INC. | $28.05 | 2023 | Dextile |
| Aroa Biosurgery Incorporated | $20.79 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.61 | 2021 | |
| Dexcom, INC. | $17.92 | 2025 | Dexcom G6 Transmitter |
| Acacia Pharma INC | $15.97 | 2021 | |
| Boston Scientific Corporation | $15.49 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.08 | 2024 | Wegovy |
| Baxter Healthcare | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Nebeker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.